{
    "id": 32604,
    "fullName": "SLC16A3 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "SLC16A3 over exp indicates an over expression of the Slc16a3 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 9123,
        "geneSymbol": "SLC16A3",
        "terms": [
            "SLC16A3",
            "MCT 3",
            "MCT 4",
            "MCT-3",
            "MCT-4",
            "MCT3",
            "MCT4"
        ]
    },
    "variant": "over exp",
    "createDate": "02/18/2020",
    "updateDate": "02/18/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20492,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BAY-8002-resistant colorectal carcinoma cells expressing SLC16A1, and overexpressing SLC16A3 and SLC16A7 demonstrated resistance to AZD3965 treatment in culture (PMID: 30115664).",
            "molecularProfile": {
                "id": 35201,
                "profileName": "SLC16A3 over exp SLC16A7 over exp"
            },
            "therapy": {
                "id": 653,
                "therapyName": "AZD3965",
                "synonyms": null
            },
            "indication": {
                "id": 80199,
                "name": "colorectal carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 16079,
                    "pubMedId": 30115664,
                    "title": "Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30115664"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20491,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD3965-resistant colorectal carcinoma cells expressing SLC16A1, and overexpressing SLC16A3 and SLC16A7 demonstrated resistance to BAY-8002 treatment in culture (PMID: 30115664).",
            "molecularProfile": {
                "id": 35201,
                "profileName": "SLC16A3 over exp SLC16A7 over exp"
            },
            "therapy": {
                "id": 8690,
                "therapyName": "BAY-8002",
                "synonyms": null
            },
            "indication": {
                "id": 80199,
                "name": "colorectal carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 16079,
                    "pubMedId": 30115664,
                    "title": "Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30115664"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35183,
            "profileName": "SLC16A3 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35201,
            "profileName": "SLC16A3 over exp SLC16A7 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}